Drug class
Liposomal immunostimulant; NOD2 agonist and macrophage activator
Mechanism of action
Mifamurtide (muramyl tripeptide phosphatidyl ethanolamine, MTP-PE) is a synthetic muramyl dipeptide derivative delivered in a liposomal formulation designed for uptake by monocytes and macrophages. It activates intracellular NOD2 receptors, stimulating cytokine release and macrophage-mediated antitumour activity. The exact contribution of each immune mechanism to clinical benefit is not fully defined.
General use cases
- Treatment of children, adolescents and young adults with high-grade resectable non-metastatic osteosarcoma after macroscopically complete surgical resection, in combination with postoperative multi-agent chemotherapy.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
